ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 163 filers reported holding ADMA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $97,634 | +94.0% | 27,272 | +100.0% | 0.00% | – |
| Q2 2023 | $50,317 | -98.7% | 13,636 | -98.9% | 0.00% | -100.0% |
| Q1 2023 | $4,014,918 | -37.8% | 1,212,966 | -27.1% | 0.02% | -72.7% |
| Q4 2022 | $6,451,594 | +31.6% | 1,662,782 | -17.6% | 0.07% | +53.5% |
| Q3 2022 | $4,902,000 | +15.1% | 2,017,265 | -6.2% | 0.04% | +34.4% |
| Q2 2022 | $4,258,000 | +1.1% | 2,150,572 | -6.5% | 0.03% | -43.9% |
| Q1 2022 | $4,210,000 | +1500.8% | 2,300,572 | +1991.4% | 0.06% | +1325.0% |
| Q3 2020 | $263,000 | -63.3% | 110,000 | -55.1% | 0.00% | -69.2% |
| Q2 2020 | $717,000 | – | 245,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $13,240,000 | 11.29% |
| Stonepine Capital Management, LLC | 7,661,690 | $25,360,194 | 8.50% |
| Altium Capital Management LP | 2,870,000 | $9,499,700 | 5.27% |
| Caligan Partners LP | 1,662,613 | $5,503,249 | 3.84% |
| AWM Investment Company, Inc. | 6,015,000 | $19,909,650 | 2.69% |
| Perceptive Advisors | 11,900,255 | $39,389,844 | 1.16% |
| EAM Investors, LLC | 1,035,752 | $3,428,339 | 0.67% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,169,500 | $3,871,045 | 0.60% |
| Magnetar Financial LLC | 7,074,722 | $23,417,330 | 0.46% |
| Virtus ETF Advisers LLC | 83,925 | $277,792 | 0.15% |